Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KAPA

Kairos Pharma, LTD.

CIK 0001962011 · NYSE American

NYSE AmericanHealth CarePharmaceutical Preparations
$0.37
↑ 0.01 (3.06%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$7.92M
P/E Ratio
-1.36
EPS
-0.30
Dividend Yield
Not covered
52W Position
3%
Beta
1.26

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.49
P/S
Not covered
EV/Revenue
Not covered
ROE
-109.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 3%
$0.33$2.11

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$5.45M
Total Assets
$6.54M
Free Cash Flow
–

Recent news